Base de lidocaína

Solución antibacteriana necesaria en alcohol bencílico de aceite esteroide:

nombre del producto: lidocaína

CASO: 137-58-6

MF: C14H22N2O

MW: 234.34

EINECS: 205-302-8

Solución antibacteriana necesaria en alcohol bencílico de aceite esteroide: 66-69° C

temperatura de almacenamiento: Almacenar en RT

solubility ethanol: 4 mg / mL

formulario: polvo

Solución antibacteriana necesaria en alcohol bencílico de aceite esteroide: prácticamente insoluble

Estabilidad: Estable. Incompatible con fuertes agentes oxidantes.

Uso: Lidocaine is a selective inverse peripheral histamine H1-receptor agonist with an IC50 of

>32 μm.

Descripción:

lidocaína, xylocaine, or lignocaine is a common local anesthetic and class-1b antiarrhythmic

drug. Lidocaine is used topically to relieve itching, incendio, and pain from skin inflammations,

injected as a dental anesthetic, or as a local anesthetic for minor surgery.It is on the World Health

Organization’s List of Essential Medicines, a list of the most important medications needed in a

basic healthcare system.

Lidocaine is the most important class-1b antiarrhythmic drug; it is used intravenously for the

treatment of ventricular arrhythmias (para infarto agudo de miocardio, envenenamiento por digoxina,

cardioversión, o cateterismo cardiaco) si la amiodarona no está disponible o está contraindicada.

Se debe administrar lidocaína para esta indicación después de la desfibrilación., RCP, and vasopressors have

been initiated. A routine prophylactic administration is no longer recommended for acute cardiac

infarction; el beneficio general de esta medida no es convincente.

Solicitud:

Lidocaine crosses the blood-brain and placental barriers, presumably by passive diffusion.

Lidocaine is metabolized rapidly by the liver, and metabolites and unchanged drug are excreted

by the kidneys. Biotransformation includes oxidative N-dealkylation, ring hydroxylation, cleavage

of the amide linkage, and conjugation. N-dealkylation, a major pathway of biotransformation,

yields the metabolites monoethylglycinexylidide and glycinexylidide. The pharmacological /

toxicological actions of these metabolites are similar to, but less potent than, those of Lidocaine.

Approximately 90% of Lidocaine administered is excreted in the form of various metabolites, Estanozolol semielaborado de la serie líquida de esteroides

less than 10% is excreted unchanged.

Resultado de la prueba de laboratorio: